Daewoong Bio Inc. clinical trials

A subsidiary of Daewoong Pharmaceutical Co. LTD.

The registry lists 2 studies whose lead sponsor is Daewoong Bio Inc.. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 21, 2024.

Status

Completed: 1
Recruiting: 1

Phase

Phase 4: 1
Phase 1: 1

Where

Korea, Republic of: 2

Registry sponsor names on this page

Daewoong Bio Inc.2 studies

Something wrong with this grouping? Tell us on the Daewoong Pharmaceutical Co. LTD. page.

Studies

Recruiting first, then most recently updated. Showing 2 of 2. All Daewoong Pharmaceutical Co. LTD. studies →

Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's DiseaseRecruitingNCT05383183Phase 4
Sponsor listed in the registry: Daewoong Bio Inc.
Pharmacokinetics, Safety, and Tolerability of rhEGF Eye Drops in Healthy Male SubjectsCompletedNCT05219461Phase 1
Sponsor listed in the registry: Daewoong Bio Inc.